1. Home
  2. EVOK vs ULY Comparison

EVOK vs ULY Comparison

Compare EVOK & ULY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVOK
  • ULY
  • Stock Information
  • Founded
  • EVOK 2007
  • ULY 2013
  • Country
  • EVOK United States
  • ULY United States
  • Employees
  • EVOK N/A
  • ULY N/A
  • Industry
  • EVOK Biotechnology: Pharmaceutical Preparations
  • ULY
  • Sector
  • EVOK Health Care
  • ULY
  • Exchange
  • EVOK Nasdaq
  • ULY Nasdaq
  • Market Cap
  • EVOK 7.1M
  • ULY 6.7M
  • IPO Year
  • EVOK 2013
  • ULY N/A
  • Fundamental
  • Price
  • EVOK $5.37
  • ULY $0.53
  • Analyst Decision
  • EVOK
  • ULY Strong Buy
  • Analyst Count
  • EVOK 0
  • ULY 1
  • Target Price
  • EVOK N/A
  • ULY $1.50
  • AVG Volume (30 Days)
  • EVOK 9.0K
  • ULY 58.2K
  • Earning Date
  • EVOK 03-13-2025
  • ULY 03-13-2025
  • Dividend Yield
  • EVOK N/A
  • ULY N/A
  • EPS Growth
  • EVOK N/A
  • ULY N/A
  • EPS
  • EVOK N/A
  • ULY 7.18
  • Revenue
  • EVOK $8,617,036.00
  • ULY $155,926,000.00
  • Revenue This Year
  • EVOK $97.35
  • ULY N/A
  • Revenue Next Year
  • EVOK $99.52
  • ULY $4.29
  • P/E Ratio
  • EVOK N/A
  • ULY $0.07
  • Revenue Growth
  • EVOK 100.35
  • ULY N/A
  • 52 Week Low
  • EVOK $3.54
  • ULY $0.41
  • 52 Week High
  • EVOK $12.32
  • ULY $3.45
  • Technical
  • Relative Strength Index (RSI)
  • EVOK 65.36
  • ULY 53.89
  • Support Level
  • EVOK $4.68
  • ULY $0.48
  • Resistance Level
  • EVOK $5.40
  • ULY $0.54
  • Average True Range (ATR)
  • EVOK 0.33
  • ULY 0.04
  • MACD
  • EVOK 0.07
  • ULY 0.00
  • Stochastic Oscillator
  • EVOK 97.46
  • ULY 74.95

About EVOK Evoke Pharma Inc.

Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.

About ULY Urgent.ly Inc.

Urgently Inc is a connected mobility assistance software platform, matching vehicle owners and operators with service professionals who deliver traditional roadside assistance, proactive maintenance and repair services. The traditional experience of a vehicle breakdown is often stressful and inconvenient, compounded by processes that lack transparency and lead to long wait times. Urgently offers an innovative alternative to this traditional experience, leveraging its digitally native software platform to match supply and demand in its network and deliver exceptional mobility assistance experiences at scale.

Share on Social Networks: